Diffuse posterior uveitis Active Not Recruiting Phase 1 / 2 Trials for Tocilizumab (DB06273)

Also known as: Posterior Uveitis / Chorioretinitis / Uveitis, Posterior / Photoretinitis / Chorioretinitis NOS / Choriodoretinitis / Chorioretinitis, unspecified

IndicationStatusPhase
DBCOND0022016 (Diffuse posterior uveitis)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01717170Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS StudyTreatment